Tumor DNA fragments help predict ovarian cancer outcomes
Ovarian cancer affects around 20,000 women in the United States each year. It is the ninth most common cancer in the U.S., but the fifth leading cause of cancer death.

The earlier ovarian cancer is caught, the more likely treatment is to be successful.

High-grade serous ovarian cancer (HGSOC) is the most malignant form of ovarian cancer, accounting for 70 percent of cases.

Currently, as with most other cancers, assessing how well a treatment is performing is difficult. In a perfect world, if doctors had full visibility of how a tumor was responding to a certain medication, they would be able to manipulate the drug type and schedule with more confidence....